As news gets out that the bivalent boosters were KNOWN not to work before authorization, FDA advisors will meet to discuss newer versions of COVID vaccines on Jan 26

Is that why all the publicity has focused on the lack of efficacy of the bivalent boosters? Cause a newer one is on the threat board?

Dr. Paul Offit published an editorial/perspective on the bivalent booster clown show yesterday in the New England Journal of Medicine. While his language is tempered, Offit makes clear that a) there has never been any benefit from these boosters compared to the original shot, b) any potential benefit will be short-lived, and c) there was neither science nor integrity involved in the decision-making to use them. What can be inferred was that FDA either was simply kicking the COVID can down the road, or was obeying orders given in secret—from whom, we do not know.

TIME Magazine reported on the story. So did The Defender, US News and World Report, CNN, the San Francisco Chronicle, and on and on.

Despite the obvious, public failure of this bivalent jab, it is still being forced on college students and given with monetary bribes to high school students (and bribes to their schools).

I cannot help but notice that these are the groups who need it least. Who are dying at unprecedented rates, suddenly, with no preceding illness.

I cannot help but notice that the youths being targeted are early in their child-bearing years. Have you noticed that too? Where is this focus on continually jabbing our youth coming from? Who is paying for it? Who is calling the shots?

BTW, I told you these boosters wouldn’t work after attending the FDA and CDC advisory meetings and reading the literature on the boosters, which was in plain sight on September 1, when the bivalent boosters were authorized.

I guess we can be thankful that only 15% of Americans took one. But that is 47 million too many, who got all pain and no gain…

Here is the info on the FDA meeting, 2 weeks from today:

https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-january-26-2023-meeting-announcement

Date: January 26, 2023 Time: 8:30 AM – 5:30 PM ET

Please note that due to the impact of the COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform.

How to Attend: 

• 01/26/2023

  You will be able to watch at the site below on Jan 26. Briefing documents should be available 48 hours earlier.